The Valley Desk

NCT02022956 · Interventional trial

Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of Age

Overall registry status Completed

Phase 1

Conditions Pharmacokinetics in Obese Adolescents

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov